2011-12 Seasonal Influenza Vaccines Effectiveness against Confirmed A(H3N2) Influenza Hospitalisation: Pooled Analysis from a European Network of Hospitals. A Pilot Study

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Rondy, Marc ^a   Puig Barbera, Joan ^b,c   Launay, Odile ^d,e,f   Duval, Xavier ^d,g   Castilla, Jesús ^h,i   Guevara, Marcela ^h,i   Costanzo, Simona ^j   de Gaetano Donati, Katleen ^k   Moren, Alain ^a  

^a EPICONCEPT   (France)

^b Centro Superior de Investigacion en Salud Publica CSISP   (Spain)

^c Centro de Salud Publica de Castellon   (Spain)

^d INSERM   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f Centre d'investigation Clinique ^*  (France)

^g BICHAT HOSPITAL   (France)

^h INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

ⁱ CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^j Fondazione di Ricerca e Cura Giovanni Paolo II   (Italy)

^k CATHOLIC UNIVERSITY   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FRANCE; HOSPITALIZATION; HUMAN; INFECTION PREVENTION; INFLUENZA A (H3N2); INFLUENZA VACCINATION; ITALY; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; SPAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; EUROPEAN UNION; FEMALE; HISTORY, 21ST CENTURY; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PILOT PROJECTS; SEASONS; YOUNG ADULT;

ORTHOMYXOVIRIDAE;

EID: 84875649922     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059681     Document Type: Article

References (38)

1. WHO {pipe} Influenza (Seasonal) (n.d.). WHO. Available: http://www.who.int/mediacentre/factsheets/fs211/en/index.html. Accessed 2013 Mar 5.
2. Müller-Pebody B, Crowcroft NS, Zambon MC, Edmunds WJ, (2006) Modelling hospital admissions for lower respiratory tract infections in the elderly in England. Epidemiol Infect 134: 1150-1157.
3. Pitman RJ, Melegaro A, Gelb D, Siddiqui MR, Gay NJ, et al. (2007) Assessing the burden of influenza and other respiratory infections in England and Wales. J Infect 54: 530-538.
4. Zhou H, Thompson WW, Viboud CG, Ringholz CM, Cheng P-Y, et al. (2012) Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis 54: 1427-1436.
5. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, et al. (2004) Influenza-associated hospitalizations in the United States. JAMA 292: 1333-1340.
6. Van Lier A, Havelaar AH, Nanda A (2007) The burden of infectious diseases in Europe: a pilot study. Euro Surveill 12.
7. Osterholm MT, Kelley NS, Sommer A, Belongia EA, (2012) Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 12: 36-44.
8. Demicheli V, Rivetti D, Deeks JJ, Jefferson TO (2004) Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev: CD001269.
9. Kissling E, Valenciano M, Cohen JM, Oroszi B, Barret A-S, et al. (2011) I-MOVE Multi-Centre Case Control Study 2010-11: Overall and Stratified Estimates of Influenza Vaccine Effectiveness in Europe. PLoS ONE 6: e27622.
10. Kissling E, Valenciano M (2012) Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12. Euro Surveill 17.
11. Valenciano M, Kissling E, Cohen J-M, Oroszi B, Barret A-S, et al. (2011) Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study. PLoS Med 8: e1000388.
12. Kissling E, Valenciano M, Falcao J, Larrauri A, Widgren K, et al. (2009) "I-MOVE" towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9. Euro Surveill 14.
13. Hardelid P, Fleming DM, Andrews N, Barley M, Durnall H, et al. (2012) Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: Results from a cohort study in general practice. Vaccine 30: 1371-1378.
14. Jimenez-Jorge S, De Mateo S, Pozo F, Casas I, Garcia Cenoz M, et al. (2012) Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012. Euro Surveill 17.
15. Castilla J, Martínez-Artola V, Salcedo E, Martínez-Baz I, Cenoz MG, et al. (2012) Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study. Vaccine 30: 195-200.
16. Seyler T, Rondy M, Moren A, Valenciano M (2012) Protocol for hospital-based case control studies to measure seasonal influenza vaccine effectiveness against laboratory confirmed influenza hospitalisations across the European Union and European Economic Area Member States.
17. Valenciano M, Kissling E, Ciancio BC, Moren A, (2010) Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine 28: 7381-7388.
18. Mahoney FI, Barthel DW, (1965) Functional evaluation: the Barthel index. Md State Med J 14: 61-65.
19. Haut Conseil de la Santé Publique (HCPS) (2011) Le Calendrier des vaccinations et les recommandations vaccinales 2011 selon l'avis du Haut Conseil de la santé publique. [2011 vaccination schedule and recommendations from the Haut conseil de la santé publique in France]. BEH 2011. Available: http://www.invs.sante.fr/content/download/4393/28810/version/4/file/beh_10_11_2011.pdf. Accessed 2013 Mar 5.
20. Madrid: Ministry of Health and Social Policy (n.d.) Prevención de la gripe. Vacunación antigripal [Influenza prevention. Recommendations for influenza vaccination]. Available: http://www.msps.es/ciudadanos/enfLesiones/enfTransmisibles/gripe/gripe.htm#prevencion. Accessed 2013 Mar 5.
21. Roma: Ministero della Salute (2012) Prevenzione e controllo dell'influenza: raccomandazioni per la stagione 2011-2012. [Prevention and control of influenza: recommendations for the season 2011-2012]. Available: http://www.normativasanitaria.it/normsan-pdf/0000/39451_1.pdf. Accessed 2013 Mar 5.
22. Community Network of Reference Laboratories (CNRL) for Human Influenza in Europe (n.d.) News- Influenza virus characterisation: Summary. Available: http://ecdc.europa.eu/en/press/news/Lists/News/ECDC_DispForm.aspx?List=32e43ee8-e230-4424-a783-85742124029a&ID=685&MasterPage=1. Accessed 2013 Mar 5.
23. Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, Botella J, (2006) Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 11: 193-206.
24. Institut de veille sanitaire (2012) Bulletin hebdomadaire grippe. Point au 2 Mai 2012. Available: http://www.invs.sante.fr/Dossiers-thematiques/Maladies-infectieuses/Maladies-a-prevention-vaccinale/Grippe/Grippe-generalites/Donnees-de-surveillance/2011-2012/Bulletin-epidemiologique-grippe.-Point-au-2-mai-2012. Accessed 2013 Mar 5.
25. Istituto superiore di sanita (2012) Rapporto Epidemiologico InfluNet- Rete italiana sorveglianza Influenza.Available: http://www.salute.gov.it/influenza/documenti/epidemiologica/Influnet_2012_17.pdf. Accessed 2013 Mar 5.
26. Castilla J, Cía F, Zubicoa J, Reina G, Martínez-Artola V, et al. (2012) Influenza outbreaks in nursing homes with high vaccination coverage in Navarre, Spain, 2011/12. Euro Surveill 17.
27. Conselleria de sanitat, Generalitat valenciana (2012) Red centinela sanitaria de la comunitat Valenciana. Sistema de vigilancia de la gripe temporada 2011-2012. Available: http://www.sp.san.gva.es/DgspPortal/docs/bolcen12_05.pdf. Accessed 2013 Mar 5.
28. Petrie JG, Ohmit SE, Johnson E, Cross RT, Monto AS, (2011) Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures. J Infect Dis 203: 1309-1315.
29. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA, (2007) Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 7: 658-666.
30. Leekha S, Zitterkopf NL, Espy MJ, Smith TF, Thompson RL, et al. (2007) Duration of influenza A virus shedding in hospitalized patients and implications for infection control. Infect Control Hosp Epidemiol 28: 1071-1076.
31. GEIG (Groupe d'Expertise et d'Information sur la Grippe) (2012) Influenza vaccination. 2011/2012 vaccination coverage and news for 2012/2013. Press Release [Vacination antigrippale. Couverture vaccinale 2011/2012 et actualités 2012/2013].
32. Jiménez-Jorge S, de Mateo S, Pozo F, Casas I, García Cenoz M, et al. (2012) Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012. Eursurveillance 17.
33. European Centre for Disease Prevention and Control (ECDC) (2012) Main surveillance developments in week 7/2012 (13-19 February 2012). Available: http://ecdc.europa.eu/en/publications/Publications/120224_SUR_Weekly_Influenza_Surveillance_Overview.pdf. Accessed 2013 Mar 5.
34. World Health Organization (WHO) (2012) Recommended composition of influenza virus vaccines for use in the 2012-2013 northern hemisphere influenza season.
35. Buxton JA, Skowronski DM, Ng H, Marion SA, Li Y, et al. (2001) Influenza revaccination of elderly travelers: antibody response to single influenza vaccination and revaccination at 12 weeks. J Infect Dis 184: 188-191.
36. Castilla J, Martínez-Baz I, Martínez-Artola V, Reina G, Pozo F, et al. (2013) Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill 18.
37. Pebody RG, Andrews N, McMenamin J, Durnall H, Ellis J, et al. (2013) Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Euro Surveill 18.
38. Kissling E, Valenciano M, Larrauri A, Oroszi B, Cohen JM, et al. (2013) Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill 18.